Docteur Natacha Opsomer SRL
Docteur Natacha Opsomer reported total assets of 170,485 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Docteur Natacha Opsomer shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -89 % Total assets +336 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Docteur Natacha Opsomer's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jun 2025
- Year ended 31 Dec 2023filed on 08 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
Docteur Natacha Opsomer's financial analysis
- Solvency1.5%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Docteur Natacha Opsomer
Docteur Natacha Opsomer's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0794.644.388
- VAT number
- BE0794644388
- Peppol
- Registered · 0208:0794644388 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Dec 2022
- Registered office
- 5002 Namur
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- General medical practice activities (NACE 86210)
Docteur Natacha Opsomer (SRL) has been based in Namur since 2022, active in: general medical practice activities. For 2025, it reports a net profit of 52,581 € and equity of 2,500 €; its revenue is not published. Its solvency stands at 1.5%, below the median of its sector (65.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Docteur Natacha Opsomer
Companies in the same business, of comparable size and area, outside its group.
- Blase Medic General medical practice activities Namur · balance sheet 170,216 €
- DR. B. Förste General medical practice activities Mechelen · balance sheet 172,521 €
- Bielders Loriane Médical General medical practice activities Les Bons Villers · balance sheet 170,699 €
- Huisarts De Paepe Lise General medical practice activities Sint-Niklaas · balance sheet 170,744 €
- Dokter Engelen-Huylebroeck General medical practice activities Tessenderlo-Ham · balance sheet 170,899 €
- Medesthet General medical practice activities Woluwe-Saint-Lambert · balance sheet 169,941 €
- Dr. Tine Beckx General medical practice activities Antwerp · balance sheet 171,072 €
- Dries Peeters, huisarts General medical practice activities Leuven · balance sheet 169,863 €
Frequently asked questions about Docteur Natacha Opsomer
What is the revenue of Docteur Natacha Opsomer?
Docteur Natacha Opsomer files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Docteur Natacha Opsomer?
In Belgium, the VAT number is the company number prefixed with BE: BE0794644388 for Docteur Natacha Opsomer, if the company is VAT-registered. Its company number (CBE) is 0794.644.388.
Where is the registered office of Docteur Natacha Opsomer?
According to the CBE register, the registered office of Docteur Natacha Opsomer is in 5002 Namur.
What is the equity of Docteur Natacha Opsomer?
At the close of the 2025 financial year, the equity of Docteur Natacha Opsomer amounts to 2,500 €, a solvency of 1.5% of total assets.
Who manages Docteur Natacha Opsomer?
The register lists 1 active mandates at Docteur Natacha Opsomer. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Docteur Natacha Opsomer
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →